Article Dans Une Revue Annals of Oncology Année : 2019

Germline-focussed analysis of tumour-only sequencing: recommendations from the ESMO Precision Medicine Working Group

L. Hawkes
  • Fonction : Auteur

Résumé

It is increasingly common in oncology practice to perform tumour sequencing using large cancer panels. For pathogenic sequence variants in cancer susceptibility genes identified on tumour-only sequencing, it is often unclear whether they are of somatic or constitutional (germline) origin. There is wide-spread disparity regarding both the extent to which systematic 'germline-focussed analysis' is carried out upon tumour sequencing data and for which variants follow-up analysis of a germline sample is carried out. Here we present analyses of paired sequencing data from 17 152 cancer samples, in which 1494 pathogenic sequence variants were identified across 65 cancer susceptibility genes. From these analyses, the European Society of Medical Oncology Precision Medicine Working Group Germline Subgroup has generated (i) recommendations regarding germline-focussed analyses of tumour-only sequencing data, (ii) indications for germline follow-up testing and (iii) guidance on patient information-giving and consent.

Fichier principal
Vignette du fichier
MANDELKER_2019.pdf (1.42 Mo) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte
Licence

Dates et versions

hal-04675463 , version 1 (22-08-2024)

Licence

Identifiants

Citer

Diana Mandelker, M. Donoghue, S. Talukdar, C. Bandlamudi, P. Srinivasan, et al.. Germline-focussed analysis of tumour-only sequencing: recommendations from the ESMO Precision Medicine Working Group. Annals of Oncology, 2019, 30 (8), pp.1221-1231. ⟨10.1093/annonc/mdz136⟩. ⟨hal-04675463⟩
40 Consultations
130 Téléchargements

Altmetric

Partager

  • More